ICYMI: A highly productive day flying AusBiotech and Medicines Australia’s Cell and Gene Catalyst flag in beautiful Sydney. 👇🏾

#AusCatalyst

Last, but not least, was the impressive Biologics Innovation Facility (“the BIF”) at UTS. Thanks to Andrew Care for hosting Orin and me for a tour. The BIF is an excellent process development and training facility - well worth connecting with Andrew if you’re keen to learn more. 🙌🏼

#AusCatalyst

Commercialisation of cell and gene therapies in Australia is both challenging and rewarding.

At the Cell and Gene Summit, Dr Michael Baker, Dr Deborah Rathjen, Sam Cobb and Dr Jerome Chal joined Dr Cameron Smith to discuss obstacles and celebrate their wins. 🙌🏼👏🏽

#CGSummit24 #AusCatalyst #AusBio24 🙏🏽

Cell & gene therapies (CGT) are revolutionising healthcare globally.

Australia’s Cell & Gene Catalyst is accelerating this industry & we have covered a lot of ground!

Read the Catalyst 2024 Impact Report: lnkd.in/gaUC9SFM

Cheers to the peak bodies, industry partners & all involved.

#AusCatalyst

First, the UK-Aus BioBridge lunch at the British Consulate General with Prof. Chris Molloy. An exciting collaborative opportunity of dynamic innovation for Australia and the UK. #WinWin It’s excellent to see that the Cell & Gene Therapy Catapult is also part of the conversation.

#AusCatalyst

Then it was onto NSW Health to meet with Anne O'Neill FTSE and her exceptional team to discuss all things GMP skills and future workforce. My thanks to Orin Chisholm and Shanny Dyer for joining this discussion and sharing key insights from their respective working groups.

#AusCatalyst

Tipping my hat to fab colleagues at Medicines Australia. I can now say Canberra has top-notch policy expertise, great company AND excellent coffee! ☕ So, if you're a bit of a Melbourne 'coffee snob', i mean, *aficionado* like me, then the place to be is 'Deakin and me'.
Thanks all! 🙏🏼
#AusCatalyst

Taking action now will position Australia as a global leader in cell and gene therapies—delivering life-changing advanced therapies to patients faster.

Read the submission here ➡️ lnkd.in/gnqdGmyn

#AusCatalyst

By collaborating and coordinating across state borders, Australia’s vibrant cell and gene ecosystem will be able to efficiently translate research, creating new industries that can scale and mature to service Australia, our region and the world.

#AusCatalyst

🔹 An Advanced Therapies Strategy as part of the overarching 𝘕𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘓𝘪𝘧𝘦 𝘚𝘤𝘪𝘦𝘯𝘤𝘦𝘴 𝘚𝘵𝘳𝘢𝘵𝘦𝘨𝘺.

#AusCatalyst

🔹 Investment in Australia’s capacity and capability across the cell and gene therapies value chain – including workforce, commercialisation skills and manufacturing; and…

#AusCatalyst

Australia’s cell and gene ecosystem has spoken. Australia’s Cell & Gene Catalyst Pre-Budget Submission 2025-26 calls for:

🔹 The development of access and regulatory pathways that drive faster and broader patient access to cell and gene therapies in Australia.

#AusCatalyst

.@merck_anz merch! The. best. Love the water bottle and coffee cup especially. Thanks to Rebecca Lee, Umesh Nair and all on the team. 🙌🏼🙏🏽 Excellent to meet with you on-site. Incredibly welcoming hosts. 🌟 #AusCatalyst

Australia’s Cell & Gene Catalyst, a joint venture of AusBiotech and Medicines Australia, is partnering with Deloitte to explore the future potential of Australia’s cell and gene ecosystem.

You can participate - do the Investment in Innovation survey: lnkd.in/gF7d5Vm4. Closes Dec 20.

#AusCatalyst